dbe11.0g/reater.(MENDATION)2.1.2UpperlimitofHb:IntheopinionoftheWorkGroup,mendroutinelymaintainingHblevelsat13.0g/reaterinESA-treatedpatients.2.1HEMOGLOBINTARGET20072.1.1IntheopinionoftheWorkGroup,selectionoftheHbtargetandselectionoftheHblevelatwhichESAtherapyisinitiatedintheindividualpatientshouldincludeconsiderationofpotentialbenefits(includingimprovementinqualityoflifeandavoidanceoftransfusion)andpotentialharms(includingtheriskoflifethreateningadverseevents).(MENDATION)2.1.2IntheopinionoftheWorkGroup,indialysisandnondialysispatientswithCKDreceivingESAtherapy,theselectedHbtargetshouldgenerallybeintherangeof11.0to12.0g/dL.(MENDATION)2.1.3IndialysisandnondialysispatientswithCKDreceivingESAtherapy,theHbtargetshouldnotbegreaterthan13.0g/dL.(ClinicalPracticeGUIDELINE–MODERATELYSTRONGEVIDENCE)
全文预览
